Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of the COvid-19 Epidemic on STRESS (COVISTRESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04308187
Recruitment Status : Not yet recruiting
First Posted : March 13, 2020
Last Update Posted : March 13, 2020
Sponsor:
Collaborators:
UMR CNRS 6024 LaPSCo, Clermont-Ferrand, France
Wittyfit, Paris, France
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand

Brief Summary:
The Coronavirus has a major influence on stress for the general population. However, data are currently non-existent concerning the perception and knowledge of the epidemic, the feeling of information from companies / establishments / governments, the means of protection used, the feelings of fear generated and their impact on feelings of stigmatization towards certain ethnic groups or categories of patients (those who cough ...), or relationships with socio-demographic factors or lifestyle.

Condition or disease
Stress, Psychological

Detailed Description:

This is an observational study using a REDCap® questionnaire via an internet link, which will be distributed by any means (Facebook, Twitter, institution mailing lists via a referent, flash codes distributed to patients and the public, etc.).

The self-questionnaire will assess stress, perception and knowledge of the epidemic, the feeling of information on the part of businesses / establishments / governments, the means of protection used the feelings of fear generated and their impact on feelings of stigmatization towards certain ethnic groups or categories of patients (those who cough ...), or relationships with socio-demographic factors or lifestyle.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 50000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 1 Day
Official Title: The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS
Estimated Study Start Date : March 11, 2020
Estimated Primary Completion Date : March 2022
Estimated Study Completion Date : March 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stress




Primary Outcome Measures :
  1. Stress [ Time Frame: Day 1 ]
    Stress level will be assessed by questionnaire


Secondary Outcome Measures :
  1. Perception and knowledge of the epidemic [ Time Frame: Day 1 ]
    Perception and knowledge of the epidemic will be assessed by questionnaire

  2. Feeling of information on the part of companies / establishments / governments [ Time Frame: Day 1 ]
    The feeling of information will be assessed by questionnaire

  3. Means of protection [ Time Frame: Day 1 ]
    the means of protection used will be assessed by questionnaire

  4. Feelings of fear generated and its impact on feelings of stigmatization towards ethnic groups or categories of patients [ Time Frame: Day 1 ]
    The feeling of fear and the impact on stigmatization will be assessed by questionnaire

  5. Sociodemographic factors and lifestyle habits [ Time Frame: Day 1 ]
    Sociodemographic factors and lifestyle habits will be assessed by questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
General population
Criteria

Inclusion Criteria:

  • Anyone volunteer to participate

Exclusion Criteria:

  • Anyone non-voluntary to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04308187


Contacts
Layout table for location contacts
Contact: Lise Laclautre 0473754963 promo_interne_drci@chu-clermontferrand.fr

Locations
Layout table for location information
France
University Hospital, Clermont-Ferrand
Clermont-Ferrand, France, 63000
Contact: Lise Laclautre    0473754963      
Principal Investigator: Frederic DUTHEIL         
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
UMR CNRS 6024 LaPSCo, Clermont-Ferrand, France
Wittyfit, Paris, France
Investigators
Layout table for investigator information
Principal Investigator: Fréderic DUTHEIL University Hospital, Clermont-Ferrand
Layout table for additonal information
Responsible Party: University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT04308187    
Other Study ID Numbers: 2020 COVISTRESS
First Posted: March 13, 2020    Key Record Dates
Last Update Posted: March 13, 2020
Last Verified: March 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Clermont-Ferrand:
Stress, Psychological
Coronavirus
Epidemics
Additional relevant MeSH terms:
Layout table for MeSH terms
Stress, Psychological
Behavioral Symptoms